
Good Science Project x FAS
Proposals to Produce ‘Good Science’ In a Time of Disruption
Scientific research in the U.S. is at a crossroads. The Trump Administration has levied deep funding cuts at science agencies and made significant changes to the federal workforce and agency structure. But challenges in how science is funded and executed long predate this acute period of disruption. For years science agencies have not been incentivized to fund risky proposals, leading to more incremental than breakthrough discoveries. Researchers are bogged down by paperwork, talent pipelines are shrinking, and even when new ideas do break through, they are getting harder to operationalize because of what has been popularized as “procedural kludge.”
As the federal government and universities confront this reality, the moment is ripe with opportunities for systematic improvements. The Federation of American Scientists (FAS) and the Good Science Project partnered to crowdsource ideas for a scientific enterprise that better serves the nation. A diverse group of experts to put forth their ideas for science reform. Through a months-long policy development sprint, we have set out to identify crucial challenges for scientific research and scientific institutions, and how to best remedy them.
Policy entrepreneurs identified these areas with outsize potential for impact:
- Accountability Improvements
- Administrative Efficiencies
- Research Lab Invigoration
Each policy memo is an independent idea based on the authors’ expertise, values, and priorities. Using their combined power to interpret complex scientific issues, while also deeply understanding the policy universe, FAS and the Good Science Project are uniquely positioned to provide policymakers with actionable directives to improve how we conduct science in the federal government.
New memos launching all week
Accountability Improvements
Confirming Hope: Validating Surrogate Endpoints to Support FDA Drug Approval Using an Inter-Agency Approach >>
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
Reshma Ramachandran, Joshua D. Wallach, Joseph Ross
Improving Research Transparency and Efficiency through Mandatory Publication of Study Results >>
Mandated publication would ensure all federal grants have outputs, whether hypotheses were supported or not, reducing repetition of ideas in future grant applications.
Administrative Efficiencies
A Cross-Health and Human Services Initiative to Cut Wasteful Spending and Improve Patient Lives >>
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Measuring Research Bureaucracy to Boost Scientific Efficiency and Innovation >>
Mandated publication would ensure all federal grants have outputs, whether hypotheses were supported or not, reducing repetition of ideas in future grant applications.